Michael H. Carrel, President, CEO, & Director at AtriCure, Inc. (ATRC), sold 25,000 shares at $45.00 ($1.1M) on 2020-05-08, disclosed to the SEC on 2020-05-08.
Open-market sale of $1.1M ATRC by President, CEO, & Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ATRC | SELL | 2021-02-04 | $1.5M | — | Filing → |
| ATRC | SELL | 2021-01-13 | $1.5M | — | Filing → |
| ATRC | SELL | 2020-12-28 | $1.4M | — | Filing → |